Risk-treatment paradox in use of statins

JAMA. 2004 Jul 14;292(2):169; author reply 169. doi: 10.1001/jama.292.2.169-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Cause of Death
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Life Expectancy
  • Risk

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors